Search Results

3226 - 3250 of 48913
TitleWireDateTime
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 04/28 07:30
Behavioral and Experimental Economics Expert Ori Heffetz Affiliates With Compass Lexecon Globe Newswire 04/28 07:30
Watsco First Quarter Performance Reflects Stabilizing Markets, Improved Operating Efficiency and Expanded Technology Adoption Globe Newswire 04/28 07:30
Watsco To Acquire Jackson Supply Company Globe Newswire 04/28 07:30
Streamex Corp. Announces First Yield Dividend Distribution for GLDY Globe Newswire 04/28 07:30
NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans Globe Newswire 04/28 07:30
FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States Globe Newswire 04/28 07:24
EarthDaily Federal Named to INSA Space Intelligence Council Globe Newswire 04/28 07:17
Microchip Expands its Family of Post-Quantum‑Ready Root of Trust Controllers for Next‑Generation Systems Globe Newswire 04/28 07:12
Sportradar Appoints Sameer Deen as Chief Operating Officer Globe Newswire 04/28 07:07
Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk Globe Newswire 04/28 07:05
reAlpha (Nasdaq: AIRE) Reports First-Quarter 2026 Financial Results Globe Newswire 04/28 07:05
Kandi Technologies Reports Full Year 2025 Financial Results Globe Newswire 04/28 07:00
CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea Globe Newswire 04/28 07:00
PPHC to Report First Quarter 2026 Financial Results on May 12, 2026 Globe Newswire 04/28 07:00
Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026 Globe Newswire 04/28 07:00
PyroGenesis Announces Appointment of Jean Mayer as Vice-President, Legal Affairs and Corporate Secretary Globe Newswire 04/28 07:00
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting Globe Newswire 04/28 07:00
Calian Signs Over $200M in Q2 Canadian Defence Contracts Globe Newswire 04/28 07:00
Velocity Trade and Kilo Capital Execute First Trades in Abaxx Spot Gold Pool Globe Newswire 04/28 07:00
Palomino Laboratories Inc. Co-Founder, Dr. Steven P. DenBaars, Receives the Prestigious 2026 IEEE Nick Holonyak Jr. Award at IEEE 2026 Honors Ceremony Globe Newswire 04/28 07:00
Coave Therapeutics to unveil OneAAVTM universal capsid at ASGCT 2026, paving the way for third generation gene therapy vectors Globe Newswire 04/28 07:00
GXO Introduces Europe’s First Autoload System for Grupa Żywiec in Poland Globe Newswire 04/28 07:00
Gogo to Report First Quarter 2026 Financial Results on 7 May, 2026 Globe Newswire 04/28 07:00
Climb Bio, Inc. Announces $110.0 Million Private Placement Globe Newswire 04/28 07:00
3226 - 3250 of 48913

News, Photo and Web Search